TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 4 | -1 | -2 | -2 | -9 | 15 | 75 | 13 |
P | %wins | 50 | 25 | 25 | 0 | 50 | 75 | 38 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/19/14 17:05 | 9/17/14 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Marchesi Vincent T | CA | D | P | 34 | 1.71 | 13 | 20 | 80 | 45 | D | -67 | -69 | -74 | -53 | -58 | -57 | -8 | -1 | -3 | -9 | -7 | -20 | 65 | 281 | |
12/20/12 19:11 | 12/20/12 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Marchesi Vincent T | CA | D | P | 19 | 4.68 | 16 | 4 | 19 | 25 | D | -47 | 12 | -9 | -13 | -1 | -11 | 6 | -1 | -2 | -3 | -1 | -1 | -4 | 24 | |
12/19/12 19:49 | 12/17/12 | EXEL | Exelixis, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | Marchesi Vincent T | CA | D | P.m | 28 | 4.72 | 16 | 6 | 40 | 21 | D | -41 | 17 | -6 | -11 | -1 | -9 | 10 | -4 | 0 | -2 | -1 | -2 | -2 | 20 | |
5/3/07 15:44 | 4/5/02 | EXEL | Exelixis Inc | DE | Health | Biolab | Commercial Physical & Biologi | Marchesi Vincent T | CA | D | P.dm | 109 | 9.11 | 8 | 12 | 120 | 22 | D | 59 | 3 | 10 | 11 | 9 | -1 | -1 | -2 | 0 | 6 | 2 | -12 | 2 | -27 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |